Tulika completed her Ph.D. in Biochemistry in 2018 at the CSIR-Indian Institute of Chemical Biology during which she worked on the different signaling aspects contributing to ovarian cancer progression, recurrence and drug resistance through biochemical and molecular biology studies. She joined Guy Sauvageau’s lab in October 2018 as a postdoctoral fellow. Her current research interests include exploring the CCC (Compound Correlation Clusters) obtained from high throughput drug screens for the identification of novel anti-AML drugs and elucidating their mechanism of action.